Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilde Inglese

Showing results (291-300 of 315) with videos related to

Pageof 32
Sort By:
Therapeutic Advances in Neurological Disorders|June 9, 2021
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategiesPietro Iaffaldano, Giuseppe Lucisano, Francesca Caputo, et al.
Radiology|February 7, 2023
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion DetectionPiet M Bouman, Samantha Noteboom, Fernando A Nobrega Santos, et al.
Neurology|September 22, 2025
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple SclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
JAMA Neurology|July 25, 2022
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple SclerosisEmilio Portaccio, Mattia Fonderico, Pietro Iaffaldano, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 28, 2019
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndromeNaila Makhani, Christine Lebrun, Aksel Siva, et al.
Multiple Sclerosis and Related Disorders|June 8, 2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple SclerosisMarta Ponzano, Irene Schiavetti, Francesca Bovis, et al.
Brain : a Journal of Neurology|September 16, 2020
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosisMaria Pia Amato, Mattia Fonderico, Emilio Portaccio, et al.
Neurology|December 21, 2022
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple SclerosisGiacomo Boffa, Alessio Signori, Luca Massacesi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 16, 2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS RegisterPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Ebiomedicine|September 26, 2021
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapiesMaria Pia Sormani, Matilde Inglese, Irene Schiavetti, et al.
Pageof 32

Showing results (291-300 of 315) with videos related to

Sort By:
Pageof 32
Therapeutic Advances in Neurological Disorders|June 9, 2021
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategiesPietro Iaffaldano, Giuseppe Lucisano, Francesca Caputo, et al.
Radiology|February 7, 2023
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion DetectionPiet M Bouman, Samantha Noteboom, Fernando A Nobrega Santos, et al.
Neurology|September 22, 2025
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple SclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
JAMA Neurology|July 25, 2022
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple SclerosisEmilio Portaccio, Mattia Fonderico, Pietro Iaffaldano, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 28, 2019
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndromeNaila Makhani, Christine Lebrun, Aksel Siva, et al.
Multiple Sclerosis and Related Disorders|June 8, 2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple SclerosisMarta Ponzano, Irene Schiavetti, Francesca Bovis, et al.
Brain : a Journal of Neurology|September 16, 2020
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosisMaria Pia Amato, Mattia Fonderico, Emilio Portaccio, et al.
Neurology|December 21, 2022
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple SclerosisGiacomo Boffa, Alessio Signori, Luca Massacesi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 16, 2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS RegisterPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Ebiomedicine|September 26, 2021
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapiesMaria Pia Sormani, Matilde Inglese, Irene Schiavetti, et al.
Pageof 32